PROCEPT BioRobotics
A territory-based sales role responsible for selling the Aquabeam Robotic System to hospitals in Japan and establishing Aquablation as the treatment of choice for benign prostatic hyperplasia (BPH). The role represents PROCEPT BioRobotics' patient-first mission and supports company growth through commercial adoption of its surgical robotics technology.
Headquarters
San Jose, California, United States
Company Size
201-500 employees
Founded
2009
PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care in urology, particularly treatments that improve men’s health. The company develops and commercializes robotic solutions such as Aquablation Therapy (AquaBeam Robotic System) and the HYDROS Robotic System to give surgeons greater precision, reproducibility, and safety. PROCEPT emphasizes clinical evidence, provider resources, training, and reimbursement support to drive adoption in hospitals and practices. Their offerings aim to modernize urologic procedures and improve outcomes for patients and clinicians.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for PROCEPT BioRobotics.
PROCEPT BioRobotics didn’t post a salary, so this is our estimate from similar listings.
PROCEPT BioRobotics (NASDAQ:PRCT) Trading Up 7.2% - Time to Buy?
1 day ago